Literature DB >> 30007993

Epilepsy in pregnancy. A comprehensive literature review and suggestions for saudi practitioners.

Inam Khuda1, Danah Aljaafari.   

Abstract

In the context of local culture and misconceptions regarding epilepsy, Saudi practitioners need a careful management plan for women with epilepsy that satisfies all the patients` needs and ensures their spouses` understanding. Such a management strategy needs to incorporate careful selection and monitoring of anti-epileptic drugs and regular counseling of patients. Female epileptic patients in the reproductive age group, no matter whether they are pregnant or not, should be managed by safest drugs from the earliest with folic acid supplementation along with adequate pre-marriage/conception counseling. All antiepileptic drugs are potentially teratogenic. However, valproic acid, phenytoin, phenobarbitone, and topiramate are least favored for use. Monotherapy is preferred over polytherapy, and the least possible dose should be used. During pregnancy, many epileptic women may need monthly drug level monitoring and dose readjustments. Normal vaginal delivery is safe in epileptic women. Post-partum follow-up with anti-epileptic drug titration may be required.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30007993     DOI: 10.17712/nsj.2018.3.20180129

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.906


  3 in total

1.  Perception and Attitude of the General Population towards Epilepsy in Jeddah, Saudi Arabia.

Authors:  Hussein Algahtani; Bader Shirah; Alhussain Alzahrani; Mostafa Shaheen
Journal:  J Epilepsy Res       Date:  2019-06-30

2.  Antiepileptic Drugs Usage in Pregnant Women with Epilepsy in Saudi Arabia.

Authors:  Hussein Algahtani; Bader Shirah; Faisal Alkahtani; Khalid Alrefaei; Abdulrahman Alamri; Ahmed Aldarmahi
Journal:  J Epilepsy Res       Date:  2019-12-31

3.  Antiseizure medications use during pregnancy and congenital malformations: A retrospective study in Saudi Arabia.

Authors:  Bshra A Alsfouk; Manal Rashed Almarzouqi; Aisha A Alsfouk; Saleh Alageel; Abdulaziz Alsemari
Journal:  Saudi Pharm J       Date:  2021-08-04       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.